Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Medtronic unveils Simplera, the latest CGM approved in Europe for people with diabetes ages two and older. A sleek, disposable device, Simplera rivals the Dexcom G7 and...
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?
Explore the profound issue of diabetes stigma and steps we can take to combat it. From the Language Matters movement to personal stories and global pledges, discover how...
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
Rising type 2 diabetes rates demand new approaches. The 2022 ADA/EASD Consensus Report emphasizes person-centered care, medications for glycemic control and weight loss...
Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...
Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...
Experts addressed rising rates of cardiovascular disease in children with diabetes at EASD 2023, emphasizing prevention and finding new biomarkers for early...
New research from the ReTUNE study of people with type 2 diabetes at a normal weight by Dr. Roy Taylor, University of Newcastle, found that type 2 diabetes is not caused...
At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...
Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.
Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...
Living with type 1 diabetes for over two decades, the author shares a harrowing tale of an unexpected diabetic complication threatening her vision. Discover her journey...
The FDA is cautioning people that the diabetes medication Ozempic – commonly prescribed off-label for weight loss – may be linked to a rare but severe side effect.
Our team is on the way to Hamburg, Germany, to cover the latest in diabetes medications, research, and technology at the European Association for the Study of Diabetes...
Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.
People dealing with access to food are more likely to have overweight, obesity, or type 2 diabetes. If you face barriers to accessing nutritious foods, there are...
Managing diabetes effectively can help protect you from autonomic neuropathy, a type of nerve damage that affects digestion, breathing, and blood pressure.
At a recent virtual panel, people with diabetes shared their powerful lived experiences on weight management, discrimination, and diabetes stigma both in and outside the...

Pages